The community pharmacy model for colorectal cancer screening: Policy insights from a national programme

被引:2
|
作者
Della Valle, P. G. [1 ]
Deandrea, S. [1 ,2 ,3 ,9 ]
Battisti, F. [4 ]
Brusa, P. [5 ]
Mantellini, P. [4 ]
Mantovani, W. [6 ]
Narne, E. [7 ]
Odone, A. [1 ]
Senore, C. [8 ]
机构
[1] Univ Pavia, Pavia, Italy
[2] Pavia Hlth Protect Agcy, Pavia, Italy
[3] Directorate Gen Hlth, Milan, Lombardy, Italy
[4] Ist Studio, Prevenz & Rete Oncolog, Florence, Italy
[5] Univ Studi Torino, Dipartimento Sci & Tecnol Farmaco, Turin, Italy
[6] Azienda Provinciale Servizi Sanitari Trento, Trento, Italy
[7] Azienda Zero, Padua, Italy
[8] AOU Citt Salute & Sci Torino, Turin, Italy
[9] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Pavia, Italy
来源
关键词
Screening; Community pharmacy; Colorectal cancer; National screening programme;
D O I
10.1016/j.sapharm.2023.08.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: In Italy, a recent national project has expanded local collaboration between colorectal (CRC) screening programmes and pharmacies to the national level. Objective: The objective of this study is to provide an overview of the existing agreements between regional authorities and pharmacy owners in Italy regarding CRC screening programmes, to make internationally available the most qualifying elements of the collaboration.Methods: We analyzed the agreements, in force on 01/08/2021, arranged between the Regions and their respective pharmacy owners, describing the process phases addressed such as the faecal occult blood test pathway and supplementary activities provided by the pharmacies together with the CRC screening kit delivery. Results: Agreements were received from 18 Regions (86% of the total). The amount of money paid for each kit varies a lot, with a range from 0 to 18 EUR. The number of process phases covered by the agreements ranged from a maximum of 16 (out of 18) to a minimum of 0. The processes most frequently covered were the supply/ delivery of kits and education/awareness of CRC screening (68.8%). Less covered processes were warehouse management and awareness of other healthcare initiatives (12.5%), and delivery of preparation for intestinal cleansing (6.3%).Conclusions: Arrangements between pharmacies and CRC screening programmes in Italy vary widely and lack a unified model. Collaboration quality standards should be set at the national/international level.
引用
收藏
页码:1595 / 1601
页数:7
相关论文
共 50 条
  • [31] Insights into colorectal cancer screening awareness: A study in the community of Taif City
    Al-Sawat, Abdullah
    Alsuwat, Mohammed S.
    Alotaibi, Riyadh H.
    Al Thobaiti, Turki K.
    Alamri, Yazan M.
    Almalki, Sultan M.
    Alkhamash, Mohanad O. M.
    Alsofiany, Eman
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2024, 16 : 1667 - 1672
  • [32] POST COLONOSCOPY COLORECTAL CANCER IN THE ENGLISH NATIONAL HEALTH SERVICE BOWEL CANCER SCREENING PROGRAMME
    Derbyshire, Edmund
    Nickerson, Claire
    Wright, Suzanne
    Morris, Eva
    Moores, Billie
    Valori, Roland
    Rutter, Matthew D.
    GUT, 2018, 67 : A9 - A9
  • [33] Downstaging of colorectal cancer by the national bowel cancer screening programme in England: first round data from the first centre
    Ellul, P.
    Fogden, E.
    Simpson, C. L.
    Nickerson, C. L. R.
    Mckaig, B. C.
    Swarbrick, E. T.
    Veitch, A. M.
    COLORECTAL DISEASE, 2010, 12 (05) : 420 - 422
  • [34] Colorectal cancer screening knowledge among community pharmacists: A national survey
    Odebunmi, Olufeyisayo O.
    Wangen, Mary
    Waters, Austin R.
    Ferrari, Renee M.
    Marciniak, Macary Weck
    Rohweder, Catherine
    Wheeler, Stephanie B.
    Brenner, Alison T.
    Shah, Parth D.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2025, 65 (01)
  • [35] Screening for colorectal cancer in renal transplant patients: Additional measures are not required in the context of a national screening programme
    Aitken, E.
    Mansouri, D.
    Crighton, E. M.
    Clancy, M. J.
    Horgan, P. G.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 129 - 130
  • [36] SCREENING FOR COLORECTAL CANCER IN RENAL TRANSPLANT PATIENTS: ADDITIONAL MEASURES ARE NOT REQUIRED IN THE CONTEXT OF A NATIONAL SCREENING PROGRAMME
    Aitken, Emma
    Martin, Damien
    Mansouri, David
    Clancy, Marc
    TRANSPLANT INTERNATIONAL, 2013, 26 : 21 - 21
  • [37] There are calls for a national screening programme for prostate cancer: what is the evidence to justify such a national screening programme?
    Green, A.
    Tait, C.
    Aboumarzouk, O.
    Somani, B. K.
    Cohen, N. P.
    SCOTTISH MEDICAL JOURNAL, 2013, 58 (02) : 64 - 68
  • [38] Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme
    Clark, Gavin R. C.
    Digby, Jayne
    Fraser, Callum G.
    Strachan, Judith A.
    Steele, Robert J. C.
    JOURNAL OF MEDICAL SCREENING, 2022, 29 (01) : 26 - 31
  • [39] PERCEPTIONS AND BELIEFS OF INVITEES TO ROUND 1 OF THE IRISH NATIONAL COLORECTAL CANCER SCREENING PROGRAMME
    O'Reilly, Susanne M.
    Katie, Hughes N.
    McNally, Sara
    Fennessy, Anne
    Mulcahy, Hugh E.
    O'Donoghue, Diarmuid
    Mooney, Therese
    Fitzpatrick, Patricia
    Cullen, Garret
    GASTROENTEROLOGY, 2018, 154 (06) : S780 - S780
  • [40] Characteristics and attitudes of first round invitees in the Irish National Colorectal Cancer Screening Programme
    O'Reilly, Susanne M.
    Hughes, Katie N.
    Mooney, Therese
    Fitzpatrick, Patricia
    O'Donoghue, Diarmuid
    McNally, Sara
    Codd, Mary
    Ryan, Elizabeth
    Doherty, Glen
    Mason, Olivia
    Mulcahy, Hugh E.
    Cullen, Garret
    FRONTLINE GASTROENTEROLOGY, 2021, 12 (05) : 374 - 379